Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination
Isfordink, Cas J.; van Dijk, Marleen; Brakenhoff, Sylvia M.; Kracht, Patricia A.M.; Arends, Joop E.; de Knegt, Robert J.; van der Valk, Marc; Drenth, Joost P.H.
(2022) European Journal of Internal Medicine, volume 101, pp. 93 - 97
(Article)
Abstract
Background & Aims: The number of chronic hepatitis C virus (HCV)-infected patients who have been lost to follow-up (LTFU) is high and threatens HCV elimination. Micro-elimination focusing on the LTFU population is a promising strategy for low-endemic countries like the Netherlands (HCV prevalence 0.16%). We therefore initiated a nationwide retrieval
... read more
project in the Netherlands targeting LTFU HCV patients. Methods: LTFU HCV-infected patients were identified using laboratory and patient records. Subsequently, the Municipal Personal Records database was queried to identify individuals eligible for retrieval, defined as being alive and with a known address in the Netherlands. These individuals were invited for re-evaluation. The primary endpoint was the number of patients successfully re-linked to care. Results: Retrieval was implemented in 45 sites in the Netherlands. Of 20,183 ever-diagnosed patients, 13,198 (65%) were known to be cured or still in care and 1,537 (8%) were LTFU and eligible for retrieval. Contact was established with 888/1,537 (58%) invited individuals; 369 (24%) had received prior successful treatment elsewhere, 131 (9%) refused re-evaluation and 251 (16%) were referred for re-evaluation. Finally, 219 (14%) were re-evaluated, of whom 172 (79%) approved additional data collection. HCV-RNA was positive in 143/172 (83%), of whom 38/143 (27%) had advanced fibrosis or cirrhosis and 123/143 (86%) commenced antiviral treatment. Conclusion: Our nationwide micro-elimination strategy accurately mapped the ever-diagnosed HCV population in the Netherlands and indicates that 27% of LTFU HCV-infected patients re-linked to care have advanced fibrosis or cirrhosis. This emphasizes the potential value of systematic retrieval for HCV elimination.
show less
Download/Full Text
Keywords: Linkage to care, Micro-elimination, People who inject drugs, Viral hepatitis, Lost to Follow-Up, Hepacivirus/genetics, Antiviral Agents/therapeutic use, Hepatitis C/epidemiology, Humans, Liver Cirrhosis/drug therapy, Hepatitis C, Chronic/drug therapy, Netherlands/epidemiology, Internal Medicine, Journal Article
ISSN: 0953-6205
Publisher: Elsevier
Note: Funding Information: CELINE was supported with an unrestricted grant from Gilead Sciences. The funder did not have any role in study design, data collection, management, analysis and/or interpretation. Wherever possible, CELINE included and expanded on data from regional retrieval projects. The REtrieval And cure of Chronic Hepatitis C (REACH) project was supported with unrestricted grants from Gilead Sciences, Merck Sharpe & Dohme (MSD), AbbVie and Bristol-Myers Squibb (BMS). The Zuyderland project was financially supported by grants from Gilead Sciences and MSD. The Track Trace & Treat project was financially supported by a grant from MSD. Projects from the Leiden University Medical Centre, Haga Teaching Hospital and Medical Centre Leeuwarden were financially unsupported. Publisher Copyright: © 2022
(Peer reviewed)